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Lampiran 5. Luaran Analisis Program Statistik 
BERAT BADAN HARI KE-1 
 
Descriptives 
Berat Badan (pre) 
 N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval for Mean 
Minimum Maximum Lower Bound Upper Bound 
ISO 11 27.18 1.537 .464 26.15 28.21 25 30 
MET+ISO 11 27.91 2.982 .899 25.91 29.91 23 32 
MET 11 28.82 2.359 .711 27.23 30.40 25 34 
K 11 27.36 1.859 .560 26.11 28.61 25 31 
Total 44 27.82 2.265 .341 27.13 28.51 23 34 
 










ISO .234 11 .096 .924 11 .351 
MET+ISO .123 11 .200
*
 .953 11 .679 
MET .197 11 .200
*
 .947 11 .602 
K .184 11 .200
*
 .900 11 .187 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Test of Homogeneity of Variances 
Berat Badan (pre) 
Levene Statistic df1 df2 Sig. 




Berat Badan (pre) 
 Sum of Squares df Mean Square F Sig. 
Between Groups 17.818 3 5.939 1.172 .332 
Within Groups 202.727 40 5.068   
















ISO Mean 26.56 .766 








5% Trimmed Mean 26.51  
Median 27.00  
Variance 5.278  
Std. Deviation 2.297  
Minimum 23  
Maximum 31  
Range 8  
Interquartile Range 3  
Skewness .386 .717 
Kurtosis 1.172 1.400 
MET+IS
O 
Mean 28.27 .935 










5% Trimmed Mean 28.03  
Median 27.00  
Variance 9.618  
Std. Deviation 3.101  
Minimum 25  
Maximum 36  
Range 11  
Interquartile Range 4  
Skewness 1.729 .661 
Kurtosis 3.375 1.279 
MET Mean 26.18 1.016 








5% Trimmed Mean 26.15  
Median 26.00  
Variance 11.364  
Std. Deviation 3.371  
Minimum 22  
57 
 
Maximum 31  
Range 9  
Interquartile Range 7  
Skewness -.096 .661 
Kurtosis -1.706 1.279 
K Mean 26.09 .780 








5% Trimmed Mean 26.10  
Median 26.00  
Variance 6.691  
Std. Deviation 2.587  
Minimum 22  
Maximum 30  
Range 8  
Interquartile Range 5  
Skewness .387 .661 
Kurtosis -.646 1.279 
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 Statistic df Sig. Statistic df Sig. 
Berat Badan (post) ISO .201 9 .200
*
 .940 9 .581 
MET+ISO .262 11 .033 .830 11 .023 
MET .253 11 .048 .869 11 .076 
K .241 11 .073 .912 11 .259 
 






 Statistic df Sig. Statistic df Sig. 
Transformasi data 
BB (post) dengan 
fungsi LG10 
ISO .196 9 .200
*
 .946 9 .643 
MET+ISO .245 11 .063 .865 11 .067 
MET .255 11 .045 .864 11 .065 
K .224 11 .131 .924 11 .349 
*. This is a lower bound of the true significance. 






Test of Homogeneity of Variances 
BB (post) yang ditransformasi 
 
Levene Statistic df1 df2 Sig. 
1.394 3 38 .259 
 
ANOVA 
BB (post) yang ditransformasi 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups .009 3 .003 1.375 .265 
Within Groups .081 38 .002   










Berat Jantung (BJ) 
 N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval for Mean 
Minimum Maximum Lower Bound Upper Bound 
ISO 9 136.67 20.616 6.872 120.82 152.51 110 170 
MET+ISO 11 129.09 23.856 7.193 113.06 145.12 100 170 
MET 11 118.18 18.878 5.692 105.50 130.86 80 150 
K 11 130.00 24.495 7.385 113.54 146.46 100 190 
Total 42 128.10 22.332 3.446 121.14 135.05 80 190 
 
 






 Statistic df Sig. Statistic Df Sig. 
Berat Jantung (BJ) ISO .186 9 .200
*
 .927 9 .453 
MET+ISO .212 11 .180 .894 11 .155 
MET .189 11 .200
*
 .958 11 .741 
K .251 11 .052 .858 11 .054 
*. This is a lower bound of the true significance. 




Test of Homogeneity of Variances 
Berat Jantung (BJ) 
Levene Statistic df1 df2 Sig. 
.187 3 38 .905 
 
ANOVA 
Berat Jantung (BJ) 
 Sum of Squares df Mean Square F Sig. 
Between Groups 1793.074 3 597.691 1.218 .317 
Within Groups 18654.545 38 490.909   








RASIO BERAT JANTUNG/PANJANG TIBIA 
 
Descriptives 
   /PT 
 N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval for Mean 
Minimum Maximum Lower Bound Upper Bound 
ISO 9 6.3489 1.00026 .33342 5.5800 7.1178 4.94 7.87 
MET+ISO 11 5.8136 1.08955 .32851 5.0817 6.5456 4.45 7.72 
MET 11 5.2864 .73816 .22256 4.7905 5.7823 3.80 6.43 
K 11 5.9555 1.10354 .33273 5.2141 6.6968 4.73 8.67 
Total 42 5.8274 1.02829 .15867 5.5069 6.1478 3.80 8.67 
 
 






 Statistic df Sig. Statistic df Sig. 
   /PT ISO .171 9 .200
*
 .947 9 .660 
MET+ISO .200 11 .200
*
 .895 11 .160 
MET .119 11 .200
*
 .974 11 .928 
K .179 11 .200
*
 .870 11 .078 
*. This is a lower bound of the true significance. 




Test of Homogeneity of Variances 
   /PT 
Levene Statistic df1 df2 Sig. 
.453 3 38 .717 
 
ANOVA 
   /PT 
 Sum of Squares df Mean Square F Sig. 
Between Groups 5.850 3 1.950 1.976 .134 
Within Groups 37.502 38 .987   










 N Mean 
Std. 
Deviation Std. Error 
95% Confidence Interval for Mean 
Minimum Maximum Lower Bound Upper Bound 
ISO 9 5.2000 .97848 .32616 4.4479 5.9521 3.55 6.52 
MET+ISO 11 4.5645 .68238 .20575 4.1061 5.0230 3.70 6.07 
MET 11 4.5518 .79004 .23820 4.0211 5.0826 3.64 5.91 
K 11 5.0018 .93065 .28060 4.3766 5.6270 4.00 7.31 
Total 42 4.8119 .86091 .13284 4.5436 5.0802 3.55 7.31 
 






 Statistic df Sig. Statistic df Sig. 
BJ/BB ISO .197 9 .200
*
 .939 9 .566 
MET+ISO .178 11 .200
*
 .934 11 .448 
MET .204 11 .200
*
 .896 11 .164 
K .185 11 .200
*
 .860 11 .058 
*. This is a lower bound of the true significance. 





Test of Homogeneity of Variances 
BJ/BB 
Levene Statistic df1 df2 Sig. 




 Sum of Squares df Mean Square F Sig. 
Between Groups 3.169 3 1.056 1.475 .237 
Within Groups 27.219 38 .716   







LUAS FIBROSIS INTERSTISIAL JANTUNG 
 
Descriptives 




ISO Mean 12169.18825 752.714126 
95% Confidence 
Interval for Mean 
Lower Bound 10433.42636  
Upper Bound 13904.95013  
5% Trimmed Mean 12192.56442  
Median 12521.64820  
Variance 5099206.997  
Std. Deviation 2258.142377  
Minimum 8921.310  
Maximum 14996.295  
Range 6074.985  
Interquartile Range 4369.786  
Skewness -.021 .717 
Kurtosis -1.620 1.400 
MET+ISO Mean 5916.91975 931.513914 
95% Confidence 
Interval for Mean 
Lower Bound 3841.37740  
Upper Bound 7992.46209  
5% Trimmed Mean 5747.35068  
Median 4732.39740  
67 
 
Variance 9544899.897  
Std. Deviation 3089.482141  
Minimum 2291.576  
Maximum 12594.507  
Range 10302.931  
Interquartile Range 3179.794  
Skewness 1.377 .661 
Kurtosis 1.243 1.279 
MET Mean 7398.68602 766.694815 
95% Confidence 
Interval for Mean 
Lower Bound 5690.38351  
Upper Bound 9106.98852  
5% Trimmed Mean 7439.15183  
Median 7504.27020  
Variance 6466030.335  
Std. Deviation 2542.839030  
Minimum 3327.990  
Maximum 10740.997  
Range 7413.007  
Interquartile Range 5182.307  
Skewness -.096 .661 
Kurtosis -1.338 1.279 




Interval for Mean 
Lower Bound 4107.56524  
Upper Bound 7121.58727  
5% Trimmed Mean 5553.80897  
Median 4828.96700  
Variance 5032004.658  
Std. Deviation 2243.213021  
Minimum 3233.384  
Maximum 9089.580  
Range 5856.196  
Interquartile Range 4855.320  
Skewness .792 .661 
Kurtosis -1.072 1.279 
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 Statistic Df Sig. Statistic df Sig. 
Luas Fibrosis 
Interstitial Jantung 
ISO .186 9 .200
*
 .919 9 .385 
MET+ISO .256 11 .043 .836 11 .028 
MET .156 11 .200
*
 .930 11 .412 
K .252 11 .050 .836 11 .028 
 
 










dengan fungsi LG10 
ISO .168 9 .200
*
 .923 9 .416 
MET+ISO .190 11 .200
*
 .937 11 .489 
MET .153 11 .200
*
 .921 11 .324 
K .196 11 .200
*
 .894 11 .155 
*. This is a lower bound of the true significance. 








Test of Homogeneity of Variances 
Luas fibrosis interstisial yang ditransformasi 
 
Levene Statistic df1 df2 Sig. 
1.492 3 38 .232 
 
ANOVA 
Luas fibrosis interstisial yang ditransformasi 
 
 Sum of Squares df Mean Square F Sig. 
Between Groups .812 3 .271 9.996 .000 
Within Groups 1.028 38 .027   








Dependent Variable:  Luas fibrosis interstisial yang ditransformasi 
LSD 
(I) Group (J) Group 
Mean Difference 
(I-J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
ISO MET+ISO .35323
*
 .07394 .000 .2035 .5029 
MET .23577
*
 .07394 .003 .0861 .3855 
K .35862
*
 .07394 .000 .2089 .5083 
MET+ISO ISO -.35323
*
 .07394 .000 -.5029 -.2035 
MET -.11746 .07015 .102 -.2595 .0246 
K .00539 .07015 .939 -.1366 .1474 
MET ISO -.23577
*
 .07394 .003 -.3855 -.0861 
MET+ISO .11746 .07015 .102 -.0246 .2595 
K .12284 .07015 .088 -.0192 .2649 
K ISO -.35862
*
 .07394 .000 -.5083 -.2089 
MET+ISO -.00539 .07015 .939 -.1474 .1366 
MET -.12284 .07015 .088 -.2649 .0192 










Case Processing Summary 
Group Total N N of Events 
Censored 
N Percent 
K 11 0 11 100.0% 
ISO 11 2 9 81.8% 
MET 11 0 11 100.0% 
MET+ISO 11 0 11 100.0% 



































 Chi-Square df Sig. 
Log Rank (Mantel-Cox) 6.292 3 .098 
Breslow (Generalized Wilcoxon) 6.286 3 .099 
Tarone-Ware 6.289 3 .098 
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[Penelitian, 2014] 
2. Yoghurt Kacang Tanah (Arachis hypogaea) sebagai Inovasi Pangan Sehat 
Anti-osteoporosis: Sebuah Studi Eksperimental pada Tikus Wistar Model 
Osteoporosis [Penelitian, 2014] 
3. Prevalensi Infeksi Cacing Cambuk (Trichuris trichiura) dan Cacing Tambang 
(Necator americanus dan Ancylostoma duodenale) pada Ibu Hamil di Kota 
Semarang [Penelitian, 2013/2014] 
 
Pengalaman Prestasi dan Mengikuti Lomba Karya Ilmiah 
1. Inovasi Susu Sapi Terfortifikasi Koenzim Q10 menggunakan 
Mikroenkapsulasi Molekuler sebagai Terapi Ajuvan pada Penderita Gagal 
Jantung dengan Komorbiditas Depresi (Gagasan Tertulis, 2014) 
2. Penerima Hibah Dana Pelaksanaan Penelitian PKM-P Tahun Anggaran 2014 
oleh Direktorat Penelitian dan Pengabdian kepada Masyarakat Ditjen 
Pendidikan Tinggi Kementerian Pendidikan Nasional (2014) 
3. Efek Pemberian Metformin terhadap Hipertrofi Miosit dan Fibrosis 
Interstisial Jantung pada Mencit Pasca-Infark Miokardium yang diinduksi 
dengan Isoproterenol (Proposal Penelitian, 2013) 
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4. Mycospray Berbasis Aspergillus niger entomopatogenik: Sebuah Inovasi 
Pengontrolan Resistensi dan Populasi Aedes aegypti dalam Upaya 
Pengendalian Dengue (Proposal Penelitian, 2013) 
5. Juara 3 Lomba Proposal Penelitian dalam Research Project. Diselenggarakan 
oleh Bidang Riset Himpunan Mahasiswa Kedokteran Umum Universitas 
Diponegoro, Semarang (2013) 
6. Juara 1 Lomba Proposal Penelitian Pekan Ilmiah Mahasiswa (PIM) Fakultas 
Kedokteran Universitas Diponegoro 2013. Diselenggarakan oleh Departemen 
Riset BEM FK KM Universitas Diponegoro, Semarang (2013) 
7. Juara 2 Lomba Proposal Penelitian Pekan Ilmiah Mahasiswa (PIM) Fakultas 
Kedokteran Universitas Diponegoro 2013. Diselenggarakan oleh Departemen 
Riset BEM FK KM Universitas Diponegoro, Semarang (2013) 
8. Juara 3 Lomba Proposal Penelitian Pekan Ilmiah Mahasiswa (PIM) Fakultas 
Kedokteran Universitas Diponegoro 2013. Diselenggarakan oleh Departemen 
Riset BEM FK KM Universitas Diponegoro, Semarang (2013) 
9. Mahasiswa Berprestasi Fakultas Kedokteran Universitas Diponegoro. Dalam 
Rangka Dies Natalis ke-52 Fakultas Kedokteran Universitas Diponegoro 
(2013) 
10. Juara 2 Cabang Sistem Digestif Indonesian Medical Olympiad (IMO) 2013. 
Diselenggarakan oleh Ikatan Senat Mahasiswa Kedokteran Indonesia 
(ISMKI) & Fakultas Kedokteran Universitas Airlangga, Surabaya (2013) 
11. Finalis 6 Besar Lomba Karya Tulis Ilmiah Gagasan Tertulis Temu Ilmiah 
Nasional (Temilnas) 2013. Diselenggarakan oleh BAPIN-ISMKI dan 
Fakultas Kedokteran Universitas Padjadjaran, Bandung (2013) 
12. Finalis Lomba Poster Ilmiah Temu Ilmiah Nasional (Temilnas) 2013. 
Diselenggarakan oleh BAPIN-ISMKI dan Fakultas Kedokteran Universitas 
Padjadjaran, Bandung (2013) 
13. Juara 1 Lomba Karya Tulis Ilmiah Gagasan Tertulis Nasional Scientific Fair  
2013. Diselenggarakan oleh Himpunan Mahasiswa Kedokteran Umum 
Universitas Diponegoro, Semarang (2013) 
14. 5th Best Literature Review in Indonesia International (bio)Medical Students' 
Congress (INAMSC), Liga Medika 2013. Conducted by Faculty of Medicine 
Universitas Indonesia, Jakarta, Indonesia (2013) 
15. Bronze-Class Certificate for Excellent Performance in Multiple Choice 
Question Round of Siriraj International Medical Microbiology and 
Immunology Competition (SIMIC) 2013. Hosted by Faculty of Medicine 
Siriraj Hospital, Mahidol University, Bangkok, Thailand (2013) 
16. Yoghurt Kacang Tanah (Arachis hypogaea) sebagai Inovasi Pangan Sehat 
Anti-osteoporosis: Sebuah Studi Eksperimental pada Tikus Wistar Model 
Osteoporosis (Proposal Penelitian, 2013) 
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17. Evidence Based Medicine: Tribendimidine sebagai Obat Alternatif Terbaru 
untuk Terapi Ascariasis (Literature Review & Poster Ilmiah, 2013) 
18. Mycospray Berbasis Aspergillus niger Entomopatogenik: Sebuah Inovasi 
Pengontrolan Resistensi dan Populasi Aedes aegypti dalam Upaya 
Pengendalian Dengue (Gagasan Tertulis, 2013) 
19. Suplementasi Quercetin pada Divine Kretek sebagai Upaya Preventif 
Karsinoma Paru (Gagasan Tertulis, 2013) 
20. Curcumin in Curcuma longa as Inflammoregulator to Prevent Carcinogenesis 
of Colitis-associated Colorectal Cancer Promoted by Commensal pks
+
 
Escherichia coli (Literature Review Paper, 2013) 
21. Efek Pemberian Yoghurt Kacang Tanah (Arachis hypogaea) terhadap Kadar 
C-Telopeptida Serum, Kadar Alkali Fosfatase Serum dan Gambaran 
Histopatologi Tulang pada Tikus Ovariektomi Model Osteoporosis (Proposal 
Penelitian, 2012) 
22. Potensi Idebenone untuk Optimalisasi Fungsi Mitokondria pada Penderita 
Leber Hereditary Optic Neuropathy (LHON) (Gagasan Tertulis, 2012) 
23. Juara 1 Lomba Proposal Penelitian dalam Research Project. Diselenggarakan 
oleh Bidang Riset Himpunan Mahasiswa Kedokteran Umum Universitas 
Diponegoro (2012) 
24. Finalis 10 Besar Scientific Paper Competition Sriwijaya Medical Science 
Olympiad (SMSO), Palembang (2012)  
 
 
